APA (7th ed.) Citation

Liu, S., Zou, Q., Chen, J., Yao, X., Guan, P., Liang, W., . . . Tan, J. (2021). Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer. The Journal of clinical investigation, 131(20), 1-15. https://doi.org/10.1172/JCI145035

Chicago Style (17th ed.) Citation

Liu, Shini, et al. "Targeting Enhancer Reprogramming to Mitigate MEK Inhibitor Resistance in Preclinical Models of Advanced Ovarian Cancer." The Journal of Clinical Investigation 131, no. 20 (2021): 1-15. https://doi.org/10.1172/JCI145035.

MLA (9th ed.) Citation

Liu, Shini, et al. "Targeting Enhancer Reprogramming to Mitigate MEK Inhibitor Resistance in Preclinical Models of Advanced Ovarian Cancer." The Journal of Clinical Investigation, vol. 131, no. 20, 2021, pp. 1-15, https://doi.org/10.1172/JCI145035.